Highland Peak Capital, LLC Bausch Health Companies Inc. Transaction History

Highland Peak Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$6.1 - $10.41 $1.48 Million - $2.53 Million	243,073 New	243,073 $1.69 Billion
Q4 2023 Feb 09, 2024	BUY	$6.53 - $8.23 $3.87 Million - $4.88 Million	593,286 New	593,286 $4.76 Billion
Q2 2023 Aug 04, 2023	BUY	$5.72 - $8.8 $2.71 Million - $4.16 Million	472,944 Added 89.28%	1,002,674 $8.02 Billion
Q1 2023 May 09, 2023	SELL	$6.28 - $9.85 $496,289 - $778,415	-79,027 Reduced 12.98%	529,730 $4.29 Billion
Q4 2022 Feb 06, 2023	BUY	$6.09 - $7.93 $3.71 Million - $4.83 Million	608,757 New	608,757 $3.82 Billion

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Highland Peak Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Highland Peak Capital, LLC with notifications on news.